Medco Creates Largest U.S. Specialty Pharmacy Through Accredo Acquisition
This article was originally published in The Pink Sheet Daily
Executive Summary
The companies' combined specialty drug sales were about $4.3 bil. in 2004. The acquisition puts Medco in a position to take a large share of Medicare Part B drug business in addition to its stake in the Part D outpatient drug benefit.
You may also be interested in...
Accredo Expands Hemophilia Business With Purchase Of Pediatric Services of America
Following Medco's acquisition of Accredo, the specialty pharmacy itself enters into a $72 mil. deal to buy "selected assets" of Pediatric Services of America.
Accredo Expands Hemophilia Business With Purchase Of Pediatric Services of America
Following Medco's acquisition of Accredo, the specialty pharmacy itself enters into a $72 mil. deal to buy "selected assets" of Pediatric Services of America.
Medco Commits $20 Mil. To Part D Development, Implementation Costs
Capital investment will be used to develop the infrastructure required to participate in the Medicare prescription drug program, including software programs and communication materials.